Up a level |
Chataway, Jeremy, De Angelis, Floriana, Connick, Peter, Parker, Richard A, Plantone, Domenico, Doshi, Anisha, John, Nevin, Stutters, Jonathan, MacManus, David, Carrasco, Ferran Prados et al (show 44 more authors)
(2020)
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
LANCET NEUROLOGY, 19 (3).
pp. 214-225.
Healy, Patricia, Galvin, Sandra, Williamson, Paula R ORCID: 0000-0001-9802-6636, Treweek, Shaun, Whiting, Caroline, Maeso, Beccy, Bray, Christopher, Brocklehurst, Peter, Moloney, Mary Clarke, Douiri, Abdel et al (show 13 more authors)
(2018)
Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) study.
Trials, 19 (1).
147-.
Connick, Peter, De Angelis, Floriana, Parker, Richard A, Plantone, Domenico, Doshi, Anisha, John, Nevin, Stutters, Jonathan, MacManus, David, Prados Carrasco, Ferran, Barkhof, Frederik et al (show 15 more authors)
(2018)
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
BMJ open, 8 (8).
e021944-e021944.